The effect of subconjunctival bevacizumab on corneal neovascularization, inflammation and re-epithelization in a rabbit model [PDF]
Clinics, 2011 PURPOSE: To evaluate the use of subconjunctival bevacizumab on corneal neovascularization in an experimental rabbit model for its effect on vessel extension, inflammation, and corneal epithelialization.
Glauco Reggiani Mello +5 more
doaj +2 more sources
Clinical Ophthalmology, 2014 Ahmed M Saeed, Tarek Tawfeek AboulNasrOphthalmology Department, Benha University, Egypt Purpose: To provide a feasible solution to the problem of failed glaucoma surgery.
Saeed AM, AboulNasr TT
doaj +1 more source
Low-dose subconjunctival bevacizumab to augment trabeculectomy for glaucoma
Clinical Ophthalmology, 2011 Mohammad-Reza Sedghipour, Ali Mostafaei, Yousef TaghaviNikoukari Ophthalmology University Hospital, Tabriz University of Medical Sciences, Tabriz, IranBackground: The purpose of this study was to assess the effect of bevacizumab in maintaining ...
Sedghipour MR, Mostafaei A, Taghavi Y
doaj +1 more source
Clinical Ophthalmology, 2014 Gian Maria Cavallini,1 Graziella Pellegrini,2 Veronica Volante,1 Pietro Ducange,1 Michele De Maria,1 Giulio Torlai,1 Caterina Benatti,1 Matteo Forlini1 1Institute of Ophthalmology, 2Centre for Regenerative Medicine “Stefano Ferrari&rdquo ...
Cavallini GM +7 more
doaj +1 more source
Current Landscape and Future Perspectives of Diabetic Retinopathy Therapy: Pharmacological Targets, Precision Laser Technology, and Clinical Evidence. [PDF]
MedComm (2020)Targeted biological agents targeting VEGF, integrin, dopamine D2 receptor, ROCK, and BCL‐XL have entered the clinical trial phase and deserve particular attention. The treatment paradigm has shifted toward personalized and precision medicine, positioning optimized SML as a promising adjunctive therapy.
Hu X +7 more
europepmc +2 more sources
BEVACIZUMAB EFFECT ON EXPRESSION OF COLLAGEN TYPE I AFTER TRABECULECTOMY
Journal of Stem Cell Research and Tissue Engineering, 2022 Objective to determine the effect of bevacizumab as an antifibrotic agent on collagen density, collagen thickness and collagen type I after trabeculectomy in rabbit.
Shinta Shinta Arta Wiguna
doaj +1 more source
Regression of Iris Neovascularization after Subconjunctival Injection of Bevacizumab [PDF]
Korean Journal of Ophthalmology, 2013 To describe three cases of neovascular glaucoma (NVG) where iris or angle neovascularization regressed remarkably after subconjunctival bevacizumab injections used as the initial treatment before pan retinal photocoagulation (PRP) and/or filtering surgery.
Ryoo, Na Kyung +2 more
openaire +2 more sources
SUBCONJUCTIVAL INJECTION OF BEVACIZUMAB IN CORNEAL NEOVASCULARIZATION [PDF]
Egyptian Journal of Clinical Ophthalmology, 2019 Purpose: The aim of this work was to assess the outcome of subconjunctival bevacizumab(Avastin) injection in patients with corneal neovascularization (NV).
Hassan, H., Abd El-badie, M., Ali, Kh.
doaj +1 more source
EFFECT OF BEVACIZUMAB ON ANGIOGENESIS INTRABECULECTOMY AREA
Journal of Stem Cell Research and Tissue Engineering, 2022 Objective to examine the effect of Bevacizumab injection to the angiogenesis which the amount and density of blood vessel as the indicators after trabeculectomy procedure.
Diana Yuliawati
doaj +1 more source
Intracameral Injection of Bevacizumab for the Treatment of Neovascular Glaucoma [PDF]
, 2011 Purpose: To assess the duration of the effect of intracameral bevacizumab in patients presenting with rubeosis iridis and neovascular glaucoma (NVG). Methods: Retrospective analysis of 24 consecutive eyes of 24 patients with decompensated NVG (> 21 mm Hg)
Haritoglou, Christos +7 more
core +1 more source